‘All Will Be Exposed': Denny Hamlin Warns Big ‘Answers' Coming in 23XI-NASCAR Charter Suit
During his Saturday presser with media before this weekend's race at Dover Motor Speedway, 23XI co-owner Denny Hamlin was asked about his concerns that he could lose Tyler Reddick after the season due to an exit clause in his deal that allows him to become a free agent if the team doesn't regain its charter.
His response is sure to go viral in NASCAR circles and make many circle a specific date later this year.
'I don't have any direct comment on that. All I can tell you, and this will be my blanket answer for all questions about this, is that if you want answers and you want to understand why this is all happening, come December 1st, you'll get the answer you're looking for,' Hamlin said. 'And all will be exposed.'
When he was asked in a follow-up question if he had any regrets about being a part of an antitrust lawsuit with Front Row Motorsports against NASCAR to question the charter system, he offered up another bold response.
'Not a chance… Mark your calendars,' said Hamlin.
23XI and Front Row Motorsports' antitrust lawsuit against NASCAR begins on December 1
23XI and Front Row were denied a restraining order by a U.S. District Court judge on Thursday to hold on to their charters. The two teams' charters were effectively revoked in June months after they filed an antitrust lawsuit claiming the NASCAR charter system was anti-competitive and they were monopolistic in their business practices.
The teams will compete at Dover as open teams. Which means they will have to qualify for each race. Fortunately, there are 40 spots at this weekend's race, and 37 teams are competing.
Hamlin is pointing to December 1 as a day for NASCAR fans to circle on their calendars because that is the official start of their lawsuit with the racing league.
Related Headlines
NASCAR starting lineup: NASCAR starting grid for Dover after Cup Series qualifying canceled
New York Mets 'Interested' In Trade for Unheralded, Cheap Reliever
MLB Rumors: Big Update Emerges on Yankees and Mets Potential Trade for Pair of Impact Pitchers
MLB Trade Rumors: 2 Teams Actively Pursuing Eugenio Suarez Trade
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons
BEACHWOOD, Ohio, July 23, 2025 /CNW/ -- Trailhead Biosystems, Inc. ( a biotechnology company pioneering the creation of induced pluripotent stem cell (iPSC)-derived human cells at scale for drug discovery and cell therapy, introduces TrailBio® A9 Dopaminergic Neurons, a powerful new tool available off-the-shelf for studying Parkinson's disease and other neurodegenerative conditions. A9 dopaminergic neurons play a critical role in movement regulation and are disproportionately affected in Parkinson's disease. Historically, researchers have lacked access to viable human models, relying instead on animal studies with limited relevance. With TrailBio® A9 Dopaminergic Neurons, scientists now have a human-specific platform to investigate disease mechanisms, develop therapies and accelerate drug discovery. "TrailBio® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems. "These cells enable researchers to study the vulnerabilities of A9 neurons, helping drive progress toward more effective treatments." "For decades, the lack of human A9 neurons has limited our ability to truly understand Parkinson's disease," added Dr. Nooshin Amini, Scientific Director at Trailhead Biosystems. "Now, with TrailBio® A9 Dopaminergic Neurons, researchers can directly study the exact cells that are most affected, offering hope for groundbreaking insights and future therapies." About Trailhead Biosystems Trailhead Biosystems, Inc. is pioneering an informatics-based approach in regenerative medicine and drug discovery. Founded in 2015 as a spinout from the Cleveland Clinic and Case Western Reserve University, Trailhead emerged from the research of CSO/CTO and founder Dr. Jan Jensen. Trailhead creates optimized human cells at scale with its proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, integrating advanced mathematical modeling with high-throughput robotic manufacturing. This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio® A9 Dopaminergic Neurons represent one of many specialized human cell types emerging from this platform, with additional cell models expected in the near future. Learn more about Trailhead Biosystems, TrailBio® A9 Dopaminergic Neurons and HD-DoE® at For more information, please contact: Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@ View original content to download multimedia: SOURCE Trailhead Biosystems Inc View original content to download multimedia:
Yahoo
6 minutes ago
- Yahoo
S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club
Block, Jack Dorsey's Bitcoin-focused payments company, is set to join the S&P 500 on Wednesday, a milestone moment for both the company and and foray further into crypto for the benchmark index. Block (XYZ), which was rebranded from Square in 2021, is the second blockchain company to join the club after cryptocurrency exchange Coinbase Global (COIN) was added to the index in mid-May. That means index fund investors will get a modest bump in exposure to the world's largest cryptocurrency bitcoin (BTCUSD). The company takes the spot vacated by Hess Corp., which was acquired by Chevron (CVX) in a deal that closed July 18. It's the third addition of the month, following The Trade Desk (TTD) and Datadog (DDOG). Since the announcement of Block's inclusion late Friday, the shares have risen 9%. Block's stock has benefited from an index effect, which refers to directional pressure on stocks when a company is added to, or removed from, the S&P 500 and other indexes. The most recent research report on the matter from S&P Dow Jones Indices, which studied the price impact of index additions and deletions from 1995 to June 2021, showed that it isn't always much of a force. The median excess returns—defined here as the difference between a stock's total return and that of the broader index—of stocks added to the index, measured from the announcement date to the effective date, was about 8% from 1995 to 1999. From 2000 to 2010, that number shrank to 3.6%, and was essentially nonexistent from 2011 to 2021. And even if an index effect shows up ahead of the official inclusion or deletion date, according to a McKinsey study, the premium or discount has a tendency to dissipate within a few months. What's new can get old pretty fast. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 minutes ago
- Yahoo
Venus Williams Has Some Smashing News About Her Personal Life
A post-match interview with Venus Williams on Tuesday revealed that the 7-time Grand Slam singles winner is engaged to Andrea Preti, an actor and former model who was seeing her play in person for the first time. The juicy tidbit emerged as the former world No. 1 celebrated her victory over Peyton Stearns at the DC Open, making Williams, 45, the oldest player to win a tour-level singles match since Martina Navratilova did at age 47 in 2004. Williams had not played a match in well over a year. An on-court chat with interviewer Rennae Stubbs took a sweet gossipy turn when she said to Williams, 'You're now an engaged woman. So, how much has Andrea helped you in this comeback? You're happy, the smile on your face. I mean, how much has he made a difference in your life?' 'Yes, my fiancé is here,' Williams answered, prompting a spectator chorus of 'wooooo!' 'He really encouraged me to keep playing,' she added. 'There were so many times where I just wanted to coast and kind of chill. Do you know how hard it is to play tennis? You guys don't know how much work goes into this, like it's 9 to 5 except you're running the whole time. Lifting weights and just like dying and then you repeat it the next day. So he encouraged me to get through this and it's wonderful to be here. He's never seen me play.' Venus Williams on her fiancées support after getting 1st singles win since 2023'My fiancée is here. He really encouraged me to keep playing. Do you know how hard it is to play tennis? It's 9 to 5 except you're running the whole time' 😭😭😭😭 — The Tennis Letter (@TheTennisLetter) July 23, 2025 Here's Preti, 37, watching her post-match press conference: And here's the couple during Milan Fashion Week in February when the two fueled engagement whispers because Williams wore a diamond ring, according to People. Their relationship dates back to at least July 2024 when they were photographed on a boat off the Amalfi Coast, the outlet reported previously. Related... 45-Year-Old Venus Williams Becomes Second-Oldest Woman To Win A Tour-Level Singles Match These Young Tennis Titans Just Got A Shot Of Confidence From One Of The Best To Ever Do It Venus Williams Sure Sounds Like She's Retiring
